chronic myelomonocytic leukaemia (CMML) | Aplastic Anemia & MDS International Foundation Return to top.

chronic myelomonocytic leukaemia (CMML)

Improving Cognitive Function in Older Adults Undergoing Stem Cell Transplant (PROACTIVE)

Cancer and treatment-related cognitive changes hinder resumption of normal routine and roles and worsen quality of life. Older adults undergoing hematopoietic cell transplantation (HCT) are at high-risk for cognitive impairment. Physical activity improves cognitive function in older adults and survivors of other cancers. We hypothesize that increasing physical activity can also improve cognitive function in this vulnerable population.

Transplant Virtual Support Group

Event Date: 
Wed, 06/16/2021 - 5:00pm (EDT)

AAMDSIF is pleased to announce that we will host a support group for patients who have been treated with a transplant, or who are considering having a transplant. The group is hosted by AAMDSIF and will be monitored to ensure the privacy and safety of our participants. 

Risk-Adapted, Individualized Treatment Strategies of Myelodysplastic Syndromes (MDS) and Chronic Myelomonocytic Leukemia (CMML)

Author(s): 
Jan Philipp Bewersdorf, Amer M Zeidan
Primary Author: 
Philipp J
Journal Title: 
Cancers
Original Publication Date: 
Mar 2021

Myelodysplastic syndrome (MDS) and chronic myelomonocytic leukemia (CMML) are two distinct blood cancers with a variable clinical symptom burden and risk of progression to

Young Adult Virtual Support Group

Event Date: 
Tue, 06/29/2021 - 6:00pm (EDT)

This virtual support group is to help support patients between the ages of 18-30 who have been diagnosed with

James Cook, MD, PhD

MD, PhD Cook, James
Professor of Pathology
Cleveland Clinic, Learner School of Medicine

James R. Cook, M.D., Ph.D., is a Professor of Pathology at the Cleveland Clinic Lerner College of Medicine.  He serves as Section Head of Hematopathology in the Department of Laboratory Medicine.  Dr. Cook's clinical interests focus on diagnostic hematopathology and molecular diagnostics.

Share with addtoany.com.